The neurology and natural history of patients with indeterminate CAG repeat length mutations of the Huntington disease gene

Journal of the Neurological Sciences

Volumn 301, Issue 1-2, 2011, Pages 14-20

  Panegyres, Peter K ^a,b   Goh, Judy G S ^b  

^a Neurosciences Unit   (Australia)

^b Neurodegenerative Disorders Research   (Australia)

Author keywords

CAG length; Huntington disease; Natural history; Neurology

Indexed keywords

ADULT; ARTICLE; ATAXIA; CAG REPEAT; CLINICAL ARTICLE; CLINICAL FEATURE; COGNITIVE DEFECT; FEMALE; FOLLOW UP; GENE MUTATION; HUMAN; HUNTINGTON CHOREA; MALE; MINI MENTAL STATE EXAMINATION; NEUROLOGIC EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RATING SCALE; SACCADIC EYE MOVEMENT;

ADULT; AGED; ASYMPTOMATIC DISEASES; ATROPHY; BRAIN; CARDIOVASCULAR DISEASES; CEREBRAL VENTRICLES; COGNITION DISORDERS; COMORBIDITY; CRANIAL IRRADIATION; CRANIOTOMY; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; HUNTINGTON DISEASE; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NERVE TISSUE PROTEINS; NEUROLOGIC EXAMINATION; NEUROPSYCHOLOGICAL TESTS; NUCLEAR PROTEINS; PENETRANCE; PHENOTYPE; SEVERITY OF ILLNESS INDEX; TRINUCLEOTIDE REPEATS;

EID: 78751584965     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jns.2010.11.015     Document Type: Article

References (36)

1. M.E. MacDonald, J.P. Vonsattel, J. Shrinidhi, N.N. Couropmitree, L.A. Cupples, and E.D. Bird Evidence for the GluR6 gene associated with younger onset age of Huntington's disease Neurology 53 1999 1330 1332
2. C. Verny, P. Allain, A. Prudean, M.C. Malinge, B. Gohier, and C. Scherer Cognitive changes in asymptomatic carriers of the Huntington disease mutation gene Eur J Neurol 14 2007 1344 1350
3. J.M.M. van der Burg, M. Björkqvist, and P. Brundin Beyond the brain: widespread pathology in Huntington's disease Lancet 8 2009 765 774
4. H.H. Ruocco, L. Bonilha, L.M. Li, I. Lopes-Cendes, and F. Cendes Longitudinal analysis of regional grey matter loss in Huntington disease: effects of the length of the expanded CAG repeat JNNP 79 2008 130 135
5. L. Cui, H. Jeong, F. Borovecki, C.N. Parkhurst, N. Tanese, and D. Krainc Transcriptional repression of PGC-1 alpha by mutant Huntingtin leads to mitochondrial dysfunction and neurodegeneration Cell 127 2006 59 69
6. P. Weydt, V.V. Pineda, A.E. Torrence, R.T. Libby, T.F. Satterfield, and E.R. Lazarowski Thermoregulatory and metabolic defects in Huntington's disease transgenic mice implicate PGC-1 alpha in Huntington's disease neurodegeneration Cell Metab 4 2006 349 362
7. S. Subramaniam, K.M. Sixt, R. Barrow, and S.H. Snyder Rhes, a striatal specific protein, mediates mutant-huntingtin cytoxicity Science 324 2009 1327 1330
8. A. Peinemann, S. Schuller, C. Pohl, T. Jahn, A. Weindl, and J. Kassubek Executive dysfunction in early stages of Huntington's disease is associated with striatal and insula atrophy: a neuropsychological and voxel-based morphometric study J Neurol Sci 239 2005 11 19
9. H.D. Rosas, D.H. Salat, S.Y. Lee, A.K. Zaleta, V. Pappu, and B. Fischl Cerebral cortex and the clinical expression of Huntington's Disease: complexity and heterogeneity Brain 131 2008 1057 1068
10. The Huntington's Disease Collaborative Research Group A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes Cell 72 1993 971 983
11. E. Vassos, M. Panas, A. Kladi, and D. Vassilopoulos Effect of CAG repeat length on psychiatric disorders in Huntington's disease J Psychiatr Res 42 2008 544 549
12. Warby S.C., Graham R.K., and Hayden M.R. Huntington Disease. Gene Reviews 2007 http://www.ncbi.nlm.nih.gov/bookshelf/br.fcgi?book=gene&part= huntington (accessed 3 October 2010)
13. The American College of Medical Genetics/American Society of Human Genetics Huntington Disease Genetic Testing Working Group ACMG/ASHG Statement: laboratory guidelines for Huntington Disease genetic testing Am J Hum Genet 62 1998 1243 1247
14. K.E. Anderson Huntington's disease and related disorders Psychiatr Clin North Am 28 2005 275 290
15. H. Lipe, and T. Bird Late onset Huntington disease: clinical and genetic characteristics of 34 cases J Neurol Sci 276 2009 159 162
16. D.C. Rubinsztein, J. Leggo, R. Coles, E. Almqvist, V. Biancalana, and J.J. Cassiman Phenotypic characterization of individuals with 30-40 CAG repeat in the Huntington Disease (HD) gene reveals HD cases with 36 repeats and apparently normal elderly individuals with 36-39 repeats Am J Med Genet 59 1999 16 22
17. P. Hayward Genes, environment and the onset of Huntington's disease Lancet Neurol 3 2004 199
18. R.H. Myers Huntington's disease genetics NeuroRx 1 2004 255 262
19. J.F. Gusella, and M.E. MacDonald Huntington's disease: the case for genetic modifiers Genome Med 21 2009 80
20. J.L. Groen, R.M. de Bie, E.M. Foncke, R.A. Roos, K.L. Leenders, and M.A. Tijssen Late-onset Huntington disease with intermediate CAG repeats: true or false? JNNP 81 2010 228 230
21. World Federation of Neurology: Research Committee Research Group on Huntington's Chorea Ethical issues policy statement on Huntington's disease molecular genetics predictive test J Neurol Sci 94 1989 327 332
22. Huntington Study Group Unified Huntington's disease rating scale: reliability and consistency Mov Disord 11 1996 136 142
23. M.N. Witjes-Ané, B. Mertens, J.P. van Vugt, A.C. Bachoud-Lévi, G.J. van Ommen, and R.A. Roos Longitudinal evaluation of "presymptomatic" carriers of Huntington's disease J Neuropsychiatry Clin Neurosci 19 2007 310 317
24. The US-Venezuela Collaborative Research Project Wexler N.S. Venezuelan kindreds reveal that genetic and environmental factors modulate Huntington's disease age of onset Proc Natl Acad Sci USA 101 2004 3498 3503
25. Brinkman R.R., Langbehn D., Falush D., Paulsen J., Hayden M.R. on behalf of an international Huntington Disease collaborative group Predicting onset and designing clinical trials for Huntington's disease http://www.cmmt.ubc.ca/ clinical/hayden (Accessed 23 February 2010)
26. F.O. Walker Huntington's disease Lancet 369 2007 218 228
27. D.R. Langbehn, M.R. Hayden, J.S. Paulsen Predict-HD Investigators of the Huntington Study Group CAG-repeat length and the age of onset in Huntington disease (HD): a review and validation study of statistical approaches Am J Med Genet B Neuropsych Genet 153B 2009 397 408
28. J.-H.J. Cha, and K.B. Kegel Triplicate repeats: Huntington's disease P.R. Hof, C.V. Mobbs, Handbook of the neuroscience of aging 2009 Academic Press London
29. S.M. Henley, E.J. Wild, N.Z. Hobbs, R.I. Scahill, G.R. Ridgway, and D.G. Macmanus Relationship between CAG repeat length and brain volume in premanifest and early Huntington's disease J Neurol 256 2009 203 212
30. Paulsen J.S., Langbehn D.R., Stout J.C., Aylward E., Ross C.A., and Nance M. Detection of Huntington's disease decades before diagnosis: the Predict-HD study JNNP 79 2008 874 880
31. P. Naarding, H.P.H. Kremer, and F.G. Zitman Huntington's disease: a review of the literature on prevalence and treatment of neuropsychiatric phenomena Eur Psychiatry 16 2001 439 445
32. D.R. Thiruvady, N. Georgiou-Karistianis, G.F. Egan, S. Ray, A. Sritharan, and M. Farrow Functional connectivity of the prefrontal cortex in Huntington's disease JNNP 78 2007 127 133
33. R.C. Wolf, N. Vasic, C. Schonfeldt-Lecuona, D. Ecker, and G.B. Landwehrmeyer Cortical dysfunction in patients with Huntington's disease during working memory performance Hum Brain Mapp 30 2009 327 339
34. Aziz N.A., van der Burg J.M., Landwehrmeyer G.B., Brundin P., Stijnen T. EHDI Study Group Weight loss in Huntington disease increases with higher CAG repeat number Neurology 71 2008 1506 1513
35. A. van Dellen, H.E. Grote, and A.J. Hannan Gene-environment interactions, neuronal dysfunction and pathological plasticity in Huntington's disease Clin Exp Pharmacol Physiol 32 2005 1007 1019
36. J.G. Morris, P. Grattan-Smith, P.K. Panegyres, P. O'Neill, Y.S. Soo, and A.O. Langlands Delayed cerebral radiation necrosis QJM 87 1994 119 129